The cold pain therapy market is projected to grow from USD 2.1 billion in 2025 to USD 3.3 billion by 2035, at a CAGR of 4.8%. OTC products will dominate with a 62.5% market share, while musculoskeletal disorders will lead the applications segment with a 40.3% share.